Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Acta Dermato-Venereologica|February 28, 2015
Methotrexate Dosing Regimen for Plaque-type Psoriasis: A Systematic Review of the Use of Test-dose, Start-dose, Dosing Scheme, Dose Adjustments, Maximum Dose and Folic Acid SupplementationStef P Menting, Paul M Dekker, Jacqueline Limpens, et al.The Journal of Dermatological Treatment|August 31, 2022
Methotrexate dosing regimen for plaque-type psoriasis: an update of a systematic reviewAstrid M van Huizen, Rosie Sikkel, Anouk G M Caron, et al.The Oncologist|March 24, 2019
Cutaneous Toxicity After Chemoradiotherapy and PD-L1 Inhibition in Two Patients with Esophageal Adenocarcinoma: More than Meets the EyeTom van den Ende, Stef P Menting, Carmen A Ambarus, et al.JAMA Dermatology|March 26, 2015
Developing a Therapeutic Range of Adalimumab Serum Concentrations in Management of Psoriasis: A Step Toward Personalized TreatmentStef P Menting, Emma Coussens, Mieke F Pouw, et al.JAMA Dermatology|December 20, 2013
Extent and consequences of antibody formation against adalimumab in patients with psoriasis: one-year follow-upStef P Menting, Paula P M van Lümig, Anna-Christa Q de Vries, et al.The Journal of Investigative Dermatology|March 25, 2014
Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patientsMarcel B M Teunissen, J Marius Munneke, Jochem H Bernink, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|April 4, 2023
Adalimumab combined with methotrexate versus adalimumab monotherapy in psoriasis: Three-year follow-up data of a single-blind randomized controlled trialAstrid M van Huizen, Gayle E van der Kraaij, Celine I Busard, et al.JAMA Dermatology|March 30, 2022
International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With PsoriasisAstrid M van Huizen, Stef P Menting, Rolland Gyulai, et al.Pageof 1